U.S. market Closed. Opens in 2 days 7 hours 53 minutes

CRDF | Cardiff Oncology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312006-01-312005-01-31
Revenue488.00K386.00K359.00K365.99K245.00K378.00K505.00K381.00K313.00K280.00K259.25K450.00K257.70K265.67K650.00KN/AN/A
Cost of RevenueN/A200.00K500.00K11.23M11.16M597.00K1.81M1.73M629.00K15.00K3.48M1.92MN/AN/AN/AN/AN/A
Gross Profit488.00K186.00K-141.00K-10.87M-10.92M-219.00K-1.31M-1.35M-316.00K265.00K-3.22M-1.47M257.70K265.67K650.00KN/AN/A
Operating Expenses45.90M40.29M29.21M19.45M16.92M16.17M22.11M38.01M24.96M15.21M10.95M5.30M3.23M5.64M3.05M4.41M1.27M
Selling, General & Admin13.04M13.18M11.84M8.22M5.76M8.01M14.23M23.00M14.36M8.54M7.00M3.38M2.32M1.95M2.22M2.53M651.70K
Research & Development32.86M27.11M17.38M11.24M11.16M8.16M7.88M15.01M10.59M6.67M3.95M1.92M910.68K3.69MN/A1.88M619.63K
Other Operating ExpensesN/A-383.00K15.00K-28.24K2.00K-237.00K-170.00K-145.00K-3.00KN/AN/A4.00KN/AN/A830.00KN/AN/A
Operating Income-45.41M-39.90M-28.86M-19.09M-16.68M-17.05M-25.60M-40.15M-25.27M-14.95M-10.69M-4.85M-2.98M-5.38M-2.39M-8.00M-5.38M
Other Expenses / Income3.97M1.20M564.00K-220.67K264.33K-72.45K689.05K941.89K-2.20M619.67K-1.12M-6.72M699.35K-69.85K-90.00K155.63K6.01K
Before Tax Income-41.44M-38.70M-28.29M-19.31M-16.41M-16.46M-24.91M-39.20M-27.47M-14.32M-11.81M-11.57M-2.28M-5.33M-2.48M-7.84M-5.37M
Income Tax ExpensesN/A-1.20M-549.00K-26.73K-262.00K617.64K716.00K-296.00K1.82M608.19K17.00K6.68M-737.59K69.85K-180.00KN/AN/A
Net Income-41.44M-37.51M-27.74M-19.28M-16.15M-16.46M-24.91M-39.20M-27.47M-14.32M-11.81M-11.57M-2.24M-5.45M-2.48M-7.84M-5.37M
Interest ExpensesN/A1.58MN/A1.52KN/A25.41K886.00K1.38M1.53M843.00K17.00KN/A56.64K115.58K-90.00KN/AN/A
Basic Shares Outstanding44.68M43.60M39.03M20.87M5.97M2.33M481.67K419.10K363.92K262.56K234.94K181.09K134.88K99.43K70.00K18.47M14.58M
Diluted Shares Outstanding44.68M43.60M39.03M20.87M5.97M2.33M481.67K420.57K367.39K264.87K235.81K181.49K134.88K99.43K70.00K18.47M14.58M
EBITDA-45.01M-39.67M-28.40M-18.84M-15.92M-15.70M-22.82M-36.76M-24.89M-14.71M-11.66M-11.53M-2.10M-5.37M-2.17M-8.00M-5.38M
EBITDA Margin-9,224.18%-10,276.17%-7,911.98%-5,147.40%-6,497.93%-4,153.35%-4,518.59%-9,647.94%-7,953.66%-5,253.70%-4,498.97%-2,561.80%-815.11%-2,021.68%-333.64%0.00%0.00%
EBIT-41.44M-37.12M-28.29M-19.31M-16.41M-15.82M-23.30M-38.12M-24.13M-12.87M-11.78M-4.88M-2.92M-5.26M-2.75M-7.84M-5.37M
EBIT Margin-8,492.01%-9,617.36%-7,880.50%-5,274.73%-6,699.59%-4,184.64%-4,614.85%-10,006.43%-7,709.34%-4,597.79%-4,542.76%-1,085.08%-1,133.18%-1,981.33%-423.08%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312006-01-312005-01-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙